Abbott Laboratories (ABT) is planning to sell $14.7 billion of bonds in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two.
Through its AbbVie Inc. pharmaceutical unit, Abbott may sell bonds in six parts ranging in size from $500 million to $4 billion, according to a person familiar with the transaction.
The offering is the largest dollar-denominated sale since February 2009, when Roche Holding AG issued $16 billion of debt, Bloomberg data show.
To contact the reporter on this story: Sarika Gangar at firstname.lastname@example.org
To contact the editor responsible for this story: John Parry at email@example.com